{
"id":"mk19_b_hm_s10",
"subspecialtyId":"hm",
"title":"Hematologic Issues in Pregnancy",
"jsonContent":{
"type":"section",
"id":"mk19_b_hm_s10",
"title":{
"__html":"Hematologic Issues in Pregnancy"
},
"titleNode":{
"type":"section-title",
"hlId":"b8bcd8",
"children":[
"Hematologic Issues in Pregnancy"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_hm_s10_1",
"title":{
"__html":"Gestational Anemia"
},
"titleNode":{
"type":"section-title",
"hlId":"a4b38e",
"children":[
"Gestational Anemia"
]
},
"children":[
{
"type":"p",
"hlId":"622936",
"children":[
"During pregnancy, an increase in plasma volume occurs that is greater than the increase in erythrocyte mass, resulting in a physiologic decrease in measured hemoglobin level, although it typically remains greater than 10.5 g/dL (105 g/L). If the hemoglobin level decreases further, additional evaluation of the anemia is warranted. Iron, vitamin B",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
", and folate levels should be measured."
]
},
{
"type":"p",
"hlId":"6683ae",
"children":[
"Worldwide, iron deficiency during pregnancy remains a significant problem. In 2017, the World Health Organization estimated that up to 60% of pregnant women have anemia, mostly attributed to iron deficiency. Because iron deficiency in pregnancy leads to anemia in infants and is associated with developmental delays, iron levels should be monitored during pregnancy and low levels supplemented. Patients with severe iron deficiency anemia in the third trimester may benefit from intravenous iron repletion."
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_2",
"title":{
"__html":"Sickle Cell Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"34ae16",
"children":[
"Sickle Cell Disease"
]
},
"children":[
{
"type":"p",
"hlId":"1fbf9c",
"children":[
"The physiologic stresses of pregnancy are especially challenging for women with sickle cell disease (SCD). Folate requirements increase because of the rapid turnover of erythrocytes, requiring additional folate supplementation. Iron and vitamin B",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"12"
]
},
" stores must also be monitored. Although expert opinion varies, the National Institutes of Health does not recommend prophylactic transfusions in pregnancy for women with sickle cell anemia. Other experts disagree, suggesting prophylactic transfusion in pregnant women during the third trimester to achieve a hemoglobin level of 9 g/dL (90 g/L) or reserving such transfusions for women with previous fetal loss, frequent acute painful events, or history of acute chest syndrome. Frequent transfusions may lead to alloimmunization, increasing the risk of hemolytic disease of the newborn. Although routine use of prophylactic transfusion is debatable, pregnant women with more severe and symptomatic anemia should be transfused as should those with acute chest syndrome or stroke. Pregnant women with SCD should be monitored closely with monthly complete blood counts."
]
},
{
"type":"p",
"hlId":"2e379f",
"children":[
"The risk of venous thromboembolism (VTE) is increased, and prophylactic anticoagulation should be administered in hospitalized patients. The increased cardiopulmonary demands of pregnancy increase the risk of pulmonary hypertension, with an associated 16% mortality risk. Suggestive clinical features (e.g., new exertional dyspnea) should be evaluated by echocardiography."
]
},
{
"type":"p",
"hlId":"c6ccc7",
"children":[
"Medications used to control SCD, such as hydroxyurea and chelating agents, must be discontinued during pregnancy. Painful vaso-occlusive crises increase during pregnancy; pain should be managed with opioid analgesics, and NSAIDs should be avoided after the 30th week of gestation to avoid premature closure of the fetal patent ductus arteriosus."
]
},
{
"type":"p",
"hlId":"bb6da5",
"children":[
"Pregnant patients with SCD are also at increased risk for complications of the pregnancy itself, including intrauterine growth restriction, eclampsia, preterm labor, placental abruption, and stillbirth."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"8a7cbc",
"children":[
"Although the use of routine prophylactic transfusion in pregnant women with sickle cell anemia remains controversial, transfusions should be given to those with more severe and symptomatic anemia or those who develop additional complications such as acute chest syndrome or stroke."
]
},
{
"type":"keypoint",
"hlId":"8da31c",
"children":[
"Medications used to control sickle cell disease, such as hydroxyurea and chelating agents, must be discontinued during pregnancy."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_3",
"title":{
"__html":"Thrombocytopenia in Pregnancy"
},
"titleNode":{
"type":"section-title",
"hlId":"feadda",
"children":[
"Thrombocytopenia in Pregnancy"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_hm_s10_3_1",
"title":{
"__html":"Gestational Thrombocytopenia"
},
"titleNode":{
"type":"section-title",
"hlId":"3021fd",
"children":[
"Gestational Thrombocytopenia"
]
},
"children":[
{
"type":"p",
"hlId":"f70dd4",
"children":[
"Gestational thrombocytopenia affects approximately 5% of pregnant women. The cause is uncertain. Most patients are asymptomatic, with platelet counts greater than 100,000/μL (100 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L), although platelet counts may reach a nadir of 70,000/μL (70 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L). Patients with gestational thrombocytopenia have no history of thrombocytopenia, and the platelet count does not decrease until late in gestation. The fetus is unaffected, intervention is unnecessary, and platelet counts spontaneously return to normal after delivery."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"54273c",
"hvc":true,
"children":[
"Patients with gestational thrombocytopenia have no history of thrombocytopenia, and because the thrombocytopenia is not severe, without predisposition to bleeding, and platelet counts resolve spontaneously, no treatment is necessary."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_3_2",
"title":{
"__html":"Immune Thrombocytopenic Purpura"
},
"titleNode":{
"type":"section-title",
"hlId":"d317ba",
"children":[
"Immune Thrombocytopenic Purpura"
]
},
"children":[
{
"type":"p",
"hlId":"cb15cb",
"children":[
"Immune thrombocytopenic purpura (ITP) (see ",
{
"type":"cross-reference",
"target":"mk19_b_hm_s6_3_2_2",
"children":[
"Platelet Disorders"
]
},
") can occur in women of childbearing age and may manifest during pregnancy. Differentiating ITP from gestational thrombocytopenia may be difficult, but features suggesting ITP include earlier presentation (first trimester), lower platelet count nadir (<70,000/μL [70 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L]), and history of thrombocytopenia before pregnancy (even if it was only mild). If the platelet count remains greater than 30,000/μL (30 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L), the pregnancy is not at risk. Patients should receive intravenous immune globulin or glucocorticoids at any time during pregnancy if the platelet count decreases to less than 30,000/μL (30 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L). The target platelet count for delivery (vaginal or cesarean section) is 50,000/μL (50 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L), and therapy should begin approximately 1 week before the expected delivery date to achieve that goal. Neuraxial anesthesia requires a platelet count greater than approximately 80,000/μL (80 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L)."
]
},
{
"type":"p",
"hlId":"e3cca7",
"children":[
"ITP autoantibodies can cross the placenta and affect the fetus; 20% to 30% of neonates are reported to have platelet counts less than 50,000/μL (50 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L), especially if an older sibling was born with thrombocytopenia. Neonatal platelet counts can continue to decrease for 2 to 5 days after delivery. Fetal thrombocytopenia is not influenced by maternal treatment with either glucocorticoids or intravenous immune globulin. Despite the increased likelihood of neonatal thrombocytopenia, the risk of intracerebral hemorrhage is less than 1% and is unaffected by cesarean section delivery."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"df505d",
"children":[
"Differentiating immune thrombocytopenic purpura from gestational thrombocytopenia may be difficult, but suggestive features include earlier presentation (first trimester), lower platelet count nadir (<70,000/μL [70 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L]), and history of thrombocytopenia before pregnancy."
]
},
{
"type":"keypoint",
"hlId":"11030e",
"children":[
"Women should receive intravenous immune globulin or glucocorticoids to treat immune thrombocytopenic purpura if the platelet count decreases to less than 30,000/μL (30 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L) at any time during the pregnancy as well as 1 week before delivery to achieve a platelet count of at least 50,000/μL (50 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L) for delivery or 80,000/μL (80 × 10",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"9"
]
},
"/L) if neuraxial anesthesia is anticipated."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_3_3",
"title":{
"__html":"Microangiopathy of Pregnancy"
},
"titleNode":{
"type":"section-title",
"hlId":"948ee1",
"children":[
"Microangiopathy of Pregnancy"
]
},
"children":[
{
"type":"p",
"hlId":"881451",
"children":[
"The thrombotic microangiopathies of pregnancy encompass a spectrum of disorders with clinical features of microangiopathic hemolytic anemia and thrombocytopenia. The differentiating features of these disorders are noted in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_hm_t37",
"wrapId":"1",
"children":[
"Table 37"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_b_hm_t37"
]
},
{
"type":"p",
"hlId":"107811",
"children":[
"The distinction between HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome, pre-eclampsia, and acute fatty liver of pregnancy may be difficult but is not crucial because management for all of these is supportive and focused on early delivery. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (see ",
{
"type":"cross-reference",
"target":"mk19_b_hm_s6_3_2",
"children":[
"Platelet Disorders"
]
},
") can also occur during pregnancy (see ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_hm_t37",
"wrapId":"2",
"children":[
"Table 37"
]
}
]
},
")"
]
},
" and may require additional therapy, including plasma exchange or the anticomplement agent eculizumab."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_b_hm_t37"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"cd7f94",
"children":[
"HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome, pre-eclampsia, and acute fatty liver of pregnancy manifest with microangiopathic hemolysis and, usually, thrombocytopenia; although distinguishing among these disorders may be difficult, the management of each is supportive and involves early delivery."
]
},
{
"type":"keypoint",
"hlId":"bc06c3",
"children":[
"Patients may develop thrombotic thrombocytopenic purpura and hemolytic uremic syndrome during pregnancy, and these conditions are important to distinguish from other causes of microangiopathic hemolysis and thrombocytopenia because more specific therapy, such as plasma exchange, may be indicated."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_4",
"title":{
"__html":"Thrombophilia and Venous Thromboembolism in Pregnancy"
},
"titleNode":{
"type":"section-title",
"hlId":"e1fe6f",
"children":[
"Thrombophilia and Venous Thromboembolism in Pregnancy"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_hm_s10_4_1",
"title":{
"__html":"Epidemiology, Pathophysiology, and Risk Factors"
},
"titleNode":{
"type":"section-title",
"hlId":"eaaa4b",
"children":[
"Epidemiology, Pathophysiology, and Risk Factors"
]
},
"children":[
{
"type":"p",
"hlId":"c9db09",
"children":[
"The risk of VTE in pregnancy is higher than in the general population, but the absolute risk is still low (<1%). Nevertheless, pulmonary emboli account for about 9% of maternal deaths. The increased risk is a result of venous stasis caused by uterine compression and increased venous capacitance, increased circulating procoagulant factors, and decreased circulating protein S. VTE risk increases further in the postpartum period after endothelial injury during delivery and an additional increase in the procoagulant factors. Factors that further increase VTE risk include multiple births, advanced maternal age, obesity, smoking, cesarean section, and varicose veins."
]
},
{
"type":"p",
"hlId":"5099fb",
"children":[
"The possibility of VTE is increased in patients with inherited thrombophilias. However, testing for these disorders in pregnancy is not routinely recommended. Deep venous thrombosis most often occurs in the left lower extremity."
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_4_2",
"title":{
"__html":"Prevention"
},
"titleNode":{
"type":"section-title",
"hlId":"c53b76",
"children":[
"Prevention"
]
},
"children":[
{
"type":"p",
"hlId":"ab31fd",
"children":[
"Patients with a history of unprovoked VTE, VTE associated with pregnancy or oral contraceptives, or thrombophilia associated with a high thrombotic risk require prophylactic antenatal and 6-week postpartum anticoagulation. Low-molecular-weight heparin (LMWH) should be used in the antenatal setting because warfarin is teratogenic and crosses the placenta, and the direct oral anticoagulants have not been studied in pregnancy. LMWH can be transitioned to unfractionated heparin around the time of delivery."
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_4_3",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"31e48e",
"children":[
"Doppler compression ultrasonography is required to diagnose deep venous thrombosis. Diagnosing a pulmonary embolism in pregnancy is challenging because of the desire to limit radiation exposure. CT pulmonary angiography leads to a higher maternal exposure than ventilation/perfusion scanning. Perfusion-only imaging can also be used to decrease radiation exposure if the chest radiograph is negative. In pregnant women with suspected pulmonary embolism, D-dimer testing and the YEARS criteria can be implemented to help avoid imaging ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_hm_t38",
"wrapId":"3",
"children":[
"Table 38"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_b_hm_t38"
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_4_4",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"6b0723",
"children":[
"LMWH is the treatment of choice for pregnant women with VTE. Therapy should begin with the standard recommended dose and then be titrated to the anti–factor Xa level (0.2-0.6 U/mL) in the third trimester if the patient has gained a substantial amount of weight. Warfarin is teratogenic and should be avoided in the first trimester (although it is the preferred treatment in some highly thromboembolic conditions such as mechanical heart valve, see ",
{
"type":"cross-reference",
"target":"mk19_b_cv_s13_3_4",
"children":[
"MKSAP 19 Cardiovascular Medicine"
]
},
"), but it is safe to resume after delivery and with breastfeeding. Thrombolytic therapy raises the risk of maternal hemorrhage and should be reserved for life-threatening situations. LMWH must be interrupted at least 24 hours before delivery; unfractionated heparin can be used instead and discontinued as labor progresses or several hours before cesarean section. Postpartum treatment is begun as soon as hemostasis is achieved. Postpartum anticoagulation should continue for at least 6 weeks. The goal is for a total anticoagulation period of 3 to 6 months."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"9e839e",
"children":[
"Patients with a history of unprovoked venous thromboembolism (VTE), VTE associated with pregnancy or oral contraceptives, or a strong hereditary thrombophilia require antenatal and postpartum anticoagulation continuing for 6 weeks after delivery."
]
},
{
"type":"keypoint",
"hlId":"f8e0cd",
"children":[
"Unfractionated or low-molecular-weight heparin should be used for anticoagulation during pregnancy in patients with venous thromboembolism because warfarin is teratogenic and crosses the placenta, and the direct oral anticoagulants have not been studied in pregnancy; warfarin is safe to resume postpartum and while breastfeeding."
]
}
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_hm_s10_5",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017;129:94-49. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28034892",
"target":"_blank"
},
"children":[
"PMID: 28034892"
]
},
" doi:10.1182/blood-2016-08-672246"
]
},
{
"type":"reference",
"children":[
"ACOG practice bulletin No. 207: thrombocytopenia in pregnancy. Obstet Gynecol. 2019;133:e181-e193. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30801473",
"target":"_blank"
},
"children":[
"PMID: 30801473"
]
},
" doi:10.1097/AOG.0000000000003100"
]
},
{
"type":"reference",
"children":[
"Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2:3317-59. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30482767",
"target":"_blank"
},
"children":[
"PMID: 30482767"
]
},
" doi:10.1182/bloodadvances.2018024802"
]
},
{
"type":"reference",
"children":[
"Huerta A, Arjona E, Portoles J, et al. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome. Kidney Int. 2018;93:450-59. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28911789",
"target":"_blank"
},
"children":[
"PMID: 28911789"
]
},
" doi:10.1016/j.kint.2017.06.022"
]
},
{
"type":"reference",
"children":[
"Righini M, Robert-Ebadi H, Elias A, et al; CT-PE-Pregnancy Group. Diagnosis of pulmonary embolism during pregnancy: A multicenter prospective management outcome study. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"https://www.acpjournals.org/doi/10.7326/M18-1670",
"target":"_blank"
},
"children":[
"Ann Intern Med"
]
},
". 2018;169:766-73. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30357273",
"target":"_blank"
},
"children":[
"PMID: 30357273"
]
}
]
},
{
"type":"reference",
"children":[
"van der Pol LM, Tromeur C, Bistervels IM, et al; Artemis Study Investigators. Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism. N Engl J Med. 2019;380:1139-49. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30893534",
"target":"_blank"
},
"children":[
"PMID: 30893534"
]
},
" doi:10.1056/NEJMoa1813865"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_b_hm_t37":{
"id":"mk19_b_hm_t37",
"number":37,
"bookId":"hm",
"title":{
"__html":"Clinical and Laboratory Features of the Thrombotic Microangiopathies of Pregnancy"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"02e1bf",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 37. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_hm_t37"
}
]
},
"Clinical and Laboratory Features of the Thrombotic Microangiopathies of Pregnancy"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21021e",
"class":"col hd l",
"children":[
"Feature"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ef554",
"class":"col hd l",
"children":[
"Pre-eclampsia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d2d08b",
"class":"col hd l",
"children":[
"HELLP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"072118",
"class":"col hd l",
"children":[
"AFLP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"657ec9",
"class":"col hd l",
"children":[
"TTP"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"03ecf8",
"class":"col hd l",
"children":[
"HUS"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01da3e",
"class":"cell txt l",
"children":[
"Hypertension"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"40421f",
"class":"cell txt l",
"children":[
"Proteinuria"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"eb7523",
"class":"cell txt l",
"children":[
"Abdominal pain"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"72ff48",
"class":"cell txt l",
"children":[
"Jaundice"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"30635f",
"class":"cell txt l",
"children":[
"Neurologic findings"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"78f621",
"class":"cell txt l",
"children":[
"Thrombocytopenia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"32615e",
"class":"cell txt l",
"children":[
"Hemolysis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"bad2e0",
"class":"cell txt l",
"children":[
"Kidney disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"528499",
"class":"cell txt l",
"children":[
"Disseminated intravascular coagulation"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"25fb0b",
"class":"cell txt l",
"children":[
"++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-10 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1bb972",
"class":"cell txt l",
"children":[
"Elevated aminotransferase levels"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26b172",
"class":"cell txt l",
"children":[
"+"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-11 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f8f006",
"class":"cell txt l",
"children":[
"Hypoglycemia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"116f37",
"class":"cell txt l",
"children":[
"+++"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ccd048",
"class":"cell txt l",
"children":[
"+/−"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"AFLP = acute fatty liver of pregnancy; HELLP = Hemolysis, Elevated Liver enzymes, and Low Platelets; HUS = hemolytic uremic syndrome; TTP = thrombotic thrombocytopenic purpura."
],
[
"+++ = always present."
],
[
"++ = usually present."
],
[
"+ = likely to be present."
],
[
"+/− = may or may not be present."
]
]
},
"mk19_b_hm_t38":{
"id":"mk19_b_hm_t38",
"number":38,
"bookId":"hm",
"title":{
"__html":"Diagnosing Pulmonary Embolism in Pregnancy Using D-dimer and YEARS Criteria<sup>a</sup>"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"27d7ba",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 38. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_hm_t38"
}
]
},
"Diagnosing Pulmonary Embolism in Pregnancy Using D-dimer and YEARS Criteria",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1626e5",
"class":"col hd l",
"children":[
"D-Dimer"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"05b034",
"class":"col hd l",
"children":[
"Number of YEARS Criteria (0-3)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f87ace",
"class":"col hd l",
"children":[
"Treatment and Imaging"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d7f8b3",
"class":"cell txt l",
"children":[
"<500 ng/mL"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"563779",
"class":"cell txt l",
"children":[
"≥1"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"57d54b",
"class":"cell txt l",
"children":[
"PE ruled out; no imaging, no anticoagulation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"3c0cb5",
"class":"cell txt l",
"children":[
"≥500 ng/mL"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"563779",
"class":"cell txt l",
"children":[
"≥1"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f61d41",
"class":"cell txt l",
"children":[
"Obtain CT angiography; begin anticoagulation if positive"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"21b9ec",
"class":"cell txt l",
"children":[
"<1000 ng/mL"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cfcd20",
"class":"cell txt l",
"children":[
"0"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"57d54b",
"class":"cell txt l",
"children":[
"PE ruled out; no imaging, no anticoagulation"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6c1d7b",
"class":"cell txt l",
"children":[
"≥1000 ng/mL"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"13dea7",
"class":"cell txt l",
"children":[
"≥0"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f61d41",
"class":"cell txt l",
"children":[
"Obtain CT angiography; begin anticoagulation if positive"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"PE = pulmonary embolism."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"YEARS criteria: clinical signs of deep venous thrombosis; hemoptysis; PE is most likely diagnosis."
],
[
"Data from van der Pol LM, Tromeur C, Bistervels IM, et al; Artemis Study Investigators. Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism. N Engl J Med. 2019;380:1139-49. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30893534",
"target":"_blank"
},
"children":[
"PMID: 30893534"
]
},
" doi:10.1056/NEJMoa1813865"
]
]
}
}
}